Health

IQVIA Applauded by Frost & Sullivan for Improving the Performance of QARA Professionals, Patient Safety, and Commercial Performance with Its AI Solutions

IQVIA's AI solutions streamline workflows, drive automation to connect process improvements, and provide insights into individual activities, improving patient safety and commercial performance. SAN ANTONIO, Sept. 11, 2024 /PRNewswire/ -- Frost & Sullivan recently assessed the artificial intelli...

2024-09-11 23:00 1640

Tinnitus Quest Launches to Find a Cure for Hearing Disorder Affecting Millions

WIESBADEN, Germany, Sept. 11, 2024 /PRNewswire/ -- Up to one in every fifty people suffers from a debilitating form of tinnitus, a chronic ringing or buzzing in the ears. It often ruins daily lives, affecting sleep, concentration, and relationships, making it a major cause of mental health probl...

2024-09-11 21:30 2730

FLOWPHYSIX ANNOUNCES STRATEGIC PARTNERSHIP WITH 3COMMA FOR INTERNATIONAL DISTRIBUTION OF INNOVATIVE THROMBECTOMY DEVICE

PLEASANTON, Calif., Sept. 11, 2024 /PRNewswire/ -- FlowPhysix™ Inc, formerly known as Expanse ICE, is pleased to announce a strategic partnership with 3comma Medical / 3comma Medical GmbH who will serve as the international commercial partner for the FLOWRUNNER™ Aspiration System. 3comma is an i...

2024-09-11 21:01 1301

Sino Innovation Lab Partners with MASSPHOTON to Launch World-Leading Air Sterilizer, Helping to Curb the Spread of Germs

HONG KONG, Sept. 11, 2024 /PRNewswire/ -- The experience of the COVID-19 pandemic has heightened global awareness of air quality and indoor environmental safety like never before. MASSPHOTON and Sino Innovation Lab have joined forces to launch an innovative medical-grade air sterilizer aimed at ...

2024-09-11 16:32 1498

Adequate legal assistance funding is vital to improving health and wellbeing outcomes

SYDNEY, Sept. 11, 2024 /PRNewswire/ -- Health Justice Australia has welcomed last week's announcement that the Australian Government will provide$3.9 billion in funding to the legal assistance sector through the new National Access to Justice Partnership. Commencing inJuly 2025, this agreement de...

2024-09-11 15:16 1464

PRODUCTLIFE GROUP ACQUIRES OUTCOMES'10, EXPANDING EUROPEAN MARKET ACCESS CAPABILITIES

PARIS, Sept. 11, 2024 /PRNewswire/ -- ProductLife Group (PLG), a global provider of regulatory, scientific, compliance, and digital transformation consulting services for the life sciences industry, is pleased to announce the acquisition of Outcomes'10, a premier Spanish life sciences consultancy...

2024-09-11 15:00 1852

Nuance Pharma completes recruitment for ENHANCE-CHINA, the phase 3 clinical trial of ensifentrine for the maintenance treatment of COPD

SHANGHAI, Sept. 11, 2024 /PRNewswire/ -- Nuance Pharma today announced it has completed the recruitment of patients for the ENHANCE-CHINA (NCT05743075) study, after planned number of patients have been successfully enrolled. The ENHANCE-CHINA study is a phase 3, randomized, double-blind, placebo-...

2024-09-11 08:00 1726

Innovent Delivers Oral Presentation on Phase 1 Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer at the 2024 WCLC

SAN FRANCISCO and SUZHOU, China, Sept. 11, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metaboli...

2024-09-11 08:00 1801

'Highly Accurate': Telix's Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology

MELBOURNE, Australia, Sept. 11, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that primary results from its Phase III ZIRCON[1] trial have been published in The Lancet Oncology, reporting that Telix's first-in-class investigational PET[2] agent,...

2024-09-11 06:46 1424

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

The companies commit to bring cutting-edge liquid biopsy testing to 20 institutions globally over the next 12 months BOSTON and ROLLE, Switzerland, Sept. 10, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medic...

2024-09-10 22:50 1209

LifeSpan Vision Ventures Invests in Remedium Bio

NORWALK, Conn., Sept. 10, 2024 /PRNewswire/ -- LifeSpan Vision Ventures today announced that it has closed an investment in Remedium Bio.   - The biotechnology company is developing a first-in-class adjus...

2024-09-10 22:17 1178

IMG Shares Top International Destinations for Autumn 2024

* IMG took a sample of its customers and reviewed more than 40,000 travel itineraries of members with upcoming travel plans betweenSeptember 1st and November 30th of 2024 to determine emerging travel trends this autumn. INDIANAPOLIS, Sept. 10, 2024 /PRNewswire/ -- IMG (International Medical Gro...

2024-09-10 21:00 1118

Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024

GAITHERSBURG, Md., Sept. 10, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for ...

2024-09-10 20:00 3028

RingConn Showcases Gen 2 Smart Ring at IFA 2024: Revolutionizing Sleep Monitoring with Integrated Sleep Apnea Detection

BERLIN, Sept. 10, 2024 /PRNewswire/ -- RingConn , a leading personal health technology company, recently showcased its newest innovation—the RingConn Gen 2 Smart Ring—at IFA 2024. This groundbreaking device is the first smart ring to feature integrated sleep ...

2024-09-10 15:00 1329

ICP DAS-BMP Reveals Advanced Engineering TPUs at Medtec China 2024

HSINCHU, Sept. 10, 2024 /PRNewswire/ -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based medical TPU (thermoplastic polyurethane) manufacturer and supplier, is excited to announce its participation in Medtec China 2024. The 18th edition of this exhibition will be held fromSeptember 25-27, 202...

2024-09-10 09:30 1593

Innovent Delivers Oral Presentation of Updated Results from a Pivotal Phase 2 Study of Dupert® (Fulzerasib) in Patients with Advanced Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation

SAN FRANCISCO and SUZHOU, China, Sept. 10, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...

2024-09-10 08:00 1865

IonOpticks partners with Adelis to accelerate global expansion and innovation

IonOpticks responds to growing global market needs for proteomics tools by partnering with Nordic private equity firm MELBOURNE, Australia and STOCKHOLM, Sept. 10, 2024 /PRNewswire/ -- IonOpticks , a leading global producer of high-performance chromatography columns, ann...

2024-09-10 06:00 1550

PATH Appoints Dr Bilal Mateen as Inaugural Chief AI Officer

SEATTLE, Sept. 10, 2024 /PRNewswire/ -- PATH, a global nonprofit dedicated to achieving health equity, today announced the appointment ofBilal Mateen as its Chief AI Officer. In this newly created role, Mateen will lead PATH's efforts to harness the power of artificial intelligence (AI) to accele...

2024-09-10 05:16 1193

Seegene Expands mpox RUO Product Lineups with Enhanced Detection Assays for Clade 1

* Introduces Novaplex™ MPXV/OPXV plus Assay (RUO) that is designed to detect Clade I, which has higher transmission and mortality rates than Clade II * Adheres to the WHO issued target product profiles and provides accurate detection of viral strains * Offers healthcare professionals with ...

2024-09-09 22:15 1946

Frost & Sullivan grants the Global Targeted Molecular Fluorescent Tracer R&D Leadership Award to Nanjing Nuoyuan Medical Devices Co., Ltd.

SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Frost & Sullivan is pleased to announce that the 18th Growth Innovation Leadership (GIL) Summit and the 3rd New Investment Event (NIE 2024), was held inShanghai from August 27 to 30, 2024, co-hosted by LeadLeo. Based on research and analysis of the global ...

2024-09-09 20:06 1271
1 ... 21222324252627 ... 580